To evaluate safety and tolerability of the Port Delivery System (PDS) in patients with neovascular age-related macular degeneration (nAMD).
Amy Pikalek
HONU
The purpose of this study is to assess iAMD disease progression, by the timeline and rates of conversion for high-risk iAMD at baseline to more advanced AMD stages.
Terri L. Young, MD, MBA Receives Prestigious Women in Ophthalmology Award
Terri L. Young, MD, MBA has devoted her career to advancing the voices of women and underserved minorities in the field of ophthalmology. She was honored for this work by the Women in Ophthalmology (WIO) …
Roomasa Channa, MD Named to Ophthalmology Management’s 40 Under 40
Amazing. That is how Roomasa Channa, MD of the University of Wisconsin Department of Ophthalmology and Visual Sciences is being described. At a special reception at the American Academy of Ophthalmology (AAO) annual meeting in …
New Pediatric Ophthalmology Rotation Announced
The UW Department of Ophthalmology and Visual Sciences is pleased to announce a new pediatric ophthalmology rotation. The new three-week rotation, which officially launched in September 2022, is designed to address the critical shortage of …
Department Activity at 2022 American Academy of Ophthalmology Annual Meeting
Join the faculty of the University of Wisconsin Department of Ophthalmology and Visual Sciences at the 2022 American Academy of Ophthalmology Annual Meeting in Chicago September 30- October 1 as we connect, share, and advance our …
Kazuya Oikawa, BVSc, PhD Awarded Knights Templar Eye Foundation Grant
Kazuya Oikawa, BVSc, PhD, a postdoctoral researcher in the McLellan Laboratory, has been awarded the Knights Templar Eye Foundation Career Starter Grant. The $70,000 award will support Dr. Oikawa’s research project “Neuroinflammation in Pediatric Glaucoma.” Primary congenital …
Department Hosts 2022 Multiphasic Phaco Course
53 residents and medical students from 10 institutions receive training in modern cataract removal techniques at DOVS’ 2022 Phacoemulsification Course. For more than two decades, medical and veterinary ophthalmology residents, UW and visiting medical students, …
TED
A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease (TED)